Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Karina Caldasia, Vice President, Investor Relations and FP&A. Please go ahead. Thank you, Shannon, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnology's second quarter 2025 earnings conference call. Earlier today, we issued a press release reporting adaptive financial results for the second quarter of 25. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the investor section of our corporate website. During the call today, management will make projections and other forward-looking statements within the mini federal security laws regarding future events and the future financial performance of the company. These statements reflect management perspective of the business as of today. Actual results may differ materially from today's forward-looking statements depending on a number of factors which are set forth in our public filings with the SEC and listed in this presentation. In addition, non-GAAP financial measures will be discussed during the call, and a reconciliation from non-GAAP to GAAP metrics c...